Jazz, Zymeworks' Ziihera trial shows significant PFS improvement, shares rally
2025-11-17 07:13:52 ET
More on Jazz Pharmaceuticals, Zymeworks, etc.
- BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript
- Zymeworks Inc. (ZYME) Q3 2025 Earnings Call Transcript
- BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript
- Saudi sovereign wealth fund cuts holdings of U.S. stocks
- Zymeworks outlines capital allocation strategy and expands ADC pipeline while targeting funding through 2027
Read the full article on Seeking Alpha
For further details see:
Jazz, Zymeworks’ Ziihera trial shows significant PFS improvement, shares rallyNASDAQ: BEIGF
BEIGF Trading
0.0% G/L:
$23.75 Last:
100 Volume:
$23.75 Open:



